The Latest Breaking News from Psoriasis

Alumis shares soar as the biotech firm’s envudeucitinib meets all primary and secondary endpoints in a Phase 3 trial. Here’s how you should play ALMS shares in 2026.

Explore common skin rash types, causes, and symptoms, including eczema and psoriasis, to understand your skin better and know when to seek treatment.

Johnson Johnson (NYSE:JNJ) and Protagonist Therapeutics Inc. (NASDAQ:PTGX) on Wednesday released new data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies of icotrokinra compared to deucravacitinib in patients with moderate-to-severe plaque psoriasis.

As August is Psoriasis Action Month – experts reveal what your skincare routine should really look like.

"Me and Beyoncé having dry scalp issues is not something I anticipated."

Grappling with his appearance, Charlie’s mental health also took a ‘massive knock’

Dr Armstrong reveals the ingredients and formulas to turn to

Help ease itching and flakiness caused by the common skin condition without compromising your hair

As a dermatologist, I often see an increase in psoriasis-related visits during winter. This chronic autoimmune skin condition characterizes red, scaly patches that may itch or cause discomfort. Cold weather, reduced sunlight, and dry indoor environments can exacerbate the condition. While the commitment to managing psoriasis is all-year-round, winter requires…